127 related articles for article (PubMed ID: 19788408)
1. Sensitivity analysis on a physiologically-based pharmacokinetic and pharmacodynamic model for diisopropylfluorophosphate-induced toxicity in mice and rats.
Chen K; Teo S; Seng KY
Toxicol Mech Methods; 2009 Oct; 19(8):486-97. PubMed ID: 19788408
[TBL] [Abstract][Full Text] [Related]
2. Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropylfluorophosphate.
Gearhart JM; Jepson GW; Clewell HJ; Andersen ME; Conolly RB
Toxicol Appl Pharmacol; 1990 Nov; 106(2):295-310. PubMed ID: 2256118
[TBL] [Abstract][Full Text] [Related]
3. Physiologically based pharmacokinetic model for the inhibition of acetylcholinesterase by organophosphate esters.
Gearhart JM; Jepson GW; Clewell HJ; Andersen ME; Conolly RB
Environ Health Perspect; 1994 Dec; 102 Suppl 11(Suppl 11):51-60. PubMed ID: 7737042
[TBL] [Abstract][Full Text] [Related]
4. In vitro inhibitory effect of aflatoxin B1 on acetylcholinesterase activity in mouse brain.
Cometa MF; Lorenzini P; Fortuna S; Volpe MT; Meneguz A; Palmery M
Toxicology; 2005 Jan; 206(1):125-35. PubMed ID: 15590113
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of diisopropylfluorophosphate, sarin, soman, and tabun on toxicity and brain acetylcholinesterase activity in mice.
Tripathi HL; Dewey WL
J Toxicol Environ Health; 1989; 26(4):437-46. PubMed ID: 2709438
[TBL] [Abstract][Full Text] [Related]
6. Calibration and validation of a physiologically based model for soman intoxication in the rat, marmoset, guinea pig and pig.
Chen K; Seng KY
J Appl Toxicol; 2012 Sep; 32(9):673-86. PubMed ID: 21433037
[TBL] [Abstract][Full Text] [Related]
7. A physiologically based pharmacokinetic and pharmacodynamic model for paraoxon in rainbow trout.
Abbas R; Hayton WL
Toxicol Appl Pharmacol; 1997 Jul; 145(1):192-201. PubMed ID: 9221837
[TBL] [Abstract][Full Text] [Related]
8. In vitro oxime protection of human red blood cell acetylcholinesterase inhibited by diisopropyl-fluorophosphate.
Lorke DE; Hasan MY; Arafat K; Kuca K; Musilek K; Schmitt A; Petroianu GA
J Appl Toxicol; 2008 May; 28(4):422-9. PubMed ID: 18344198
[TBL] [Abstract][Full Text] [Related]
9. Protection from the toxicity of diisopropylfluorophosphate by adeno-associated virus expressing acetylcholinesterase.
Li B; Duysen EG; Poluektova LY; Murrin LC; Lockridge O
Toxicol Appl Pharmacol; 2006 Jul; 214(2):152-65. PubMed ID: 16443250
[TBL] [Abstract][Full Text] [Related]
10. A physiologically based pharmacokinetic/pharmacodynamic model for carbofuran in Sprague-Dawley rats using the exposure-related dose estimating model.
Zhang X; Tsang AM; Okino MS; Power FW; Knaak JB; Harrison LS; Dary CC
Toxicol Sci; 2007 Dec; 100(2):345-59. PubMed ID: 17804862
[TBL] [Abstract][Full Text] [Related]
11. Adenosine A1 receptor agonist N6-cyclopentyladenosine affects the inactivation of acetylcholinesterase in blood and brain by sarin.
Bueters TJ; Joosen MJ; van Helden HP; Ijzerman AP; Danhof M
J Pharmacol Exp Ther; 2003 Mar; 304(3):1307-13. PubMed ID: 12604711
[TBL] [Abstract][Full Text] [Related]
12. Diisopropylfluorophosphate inhibits acetylcholinesterase activity and disrupts somitogenesis in the zebrafish.
Hanneman EH
J Exp Zool; 1992 Aug; 263(1):41-53. PubMed ID: 1645120
[TBL] [Abstract][Full Text] [Related]
13. Eight new bispyridinium oximes in comparison with the conventional oximes pralidoxime and obidoxime: in vivo efficacy to protect from diisopropylfluorophosphate toxicity.
Lorke DE; Nurulain SM; Hasan MY; Kuca K; Musilek K; Petroianu GA
J Appl Toxicol; 2008 Oct; 28(7):920-8. PubMed ID: 18548743
[TBL] [Abstract][Full Text] [Related]
14. Organophosphate-induced convulsions and prevention of neuropathological damages.
Tuovinen K
Toxicology; 2004 Mar; 196(1-2):31-9. PubMed ID: 15036754
[TBL] [Abstract][Full Text] [Related]
15. Increased diisopropylfluorophosphate-induced toxicity in mu-opioid receptor knockout mice.
Tien LT; Fan LW; Ma T; Loh HH; Ho IK
J Neurosci Res; 2004 Oct; 78(2):259-67. PubMed ID: 15378609
[TBL] [Abstract][Full Text] [Related]
16. Strain and regional dependence of alternate splicing of acetylcholinesterase in the murine brain following stress or treatment with diisopropylfluorophosphate.
Livneh U; Dori A; Katzav A; Kofman O
Behav Brain Res; 2010 Jun; 210(1):107-15. PubMed ID: 20178819
[TBL] [Abstract][Full Text] [Related]
17. Modification of acetylcholinesterase during adaptation to chronic, subacute paraoxon application in rat.
Milatovic D; Dettbarn WD
Toxicol Appl Pharmacol; 1996 Jan; 136(1):20-8. PubMed ID: 8560475
[TBL] [Abstract][Full Text] [Related]
18. Bayesian calibration of a physiologically based pharmacokinetic/pharmacodynamic model of carbaryl cholinesterase inhibition.
Nong A; Tan YM; Krolski ME; Wang J; Lunchick C; Conolly RB; Clewell HJ
J Toxicol Environ Health A; 2008; 71(20):1363-81. PubMed ID: 18704829
[TBL] [Abstract][Full Text] [Related]
19. A physiologically based pharmacokinetic (PB/PK) model for multiple exposure routes of soman in multiple species.
Sweeney RE; Langenberg JP; Maxwell DM
Arch Toxicol; 2006 Nov; 80(11):719-31. PubMed ID: 16718492
[TBL] [Abstract][Full Text] [Related]
20. Kinetic analysis of the in vitro inhibition, aging, and reactivation of brain acetylcholinesterase from rat and channel catfish by paraoxon and chlorpyrifos-oxon.
Carr RL; Chambers JE
Toxicol Appl Pharmacol; 1996 Aug; 139(2):365-73. PubMed ID: 8806854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
